BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24705283)

  • 1. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.
    Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z
    PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
    Suzuki S; Ishikawa K
    Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
    Liu Z; Hartman YE; Warram JM; Knowles JA; Sweeny L; Zhou T; Rosenthal EL
    Mol Cancer Res; 2011 Aug; 9(8):1008-17. PubMed ID: 21665938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
    Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
    Huang T; Chen MH; Wu MY; Wu XY
    Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
    Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
    BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A-EMMPRIN interaction induces invasion of head and neck squamous cell carcinoma.
    Takahashi M; Suzuki S; Ishikawa K
    Oncol Rep; 2012 Jan; 27(1):198-203. PubMed ID: 21956400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
    Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
    Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
    J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of EMMPRIN expression in ovarian epithelial carcinomas.
    Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
    Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-10/stromelysin-2 promotes invasion of head and neck cancer.
    Deraz EM; Kudo Y; Yoshida M; Obayashi M; Tsunematsu T; Tani H; Siriwardena SB; Keikhaee MR; Qi G; Iizuka S; Ogawa I; Campisi G; Lo Muzio L; Abiko Y; Kikuchi A; Takata T
    PLoS One; 2011; 6(10):e25438. PubMed ID: 21998657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
    Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
    Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].
    Kondakova IV; Klisho EV; savenkova OV; Kakurina GV; Choĭnzonov EL; Shishkin DA; Mukhamedov MP
    Biomed Khim; 2008; 54(5):555-60. PubMed ID: 19105397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
    Kim HS; Kim HJ; Lee MR; Han I
    BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
    Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
    Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.
    Zhu H; Zhao J; Zhu B; Collazo J; Gal J; Shi P; Liu L; Ström AL; Lu X; McCann RO; Toborek M; Kyprianou N
    Prostate; 2012 Jan; 72(1):72-81. PubMed ID: 21563192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.